Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa
NCT ID: NCT06368375
Last Updated: 2024-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2023-01-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures
NCT03845218
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
NCT04868916
Retrospective Natural History Study of Retinitis Pigmentosa
NCT03975543
Biomarkers in Retinitis Pigmentosa
NCT06306690
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
NCT06517940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Kuehlewein, MD
Role: PRINCIPAL_INVESTIGATOR
Department for Ophthalmology, University of Tuebingen
Susanne Kohl, PhD
Role: PRINCIPAL_INVESTIGATOR
Molecular Genetics Laboratory, Department for Ophthalmology, University of Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRPF31-3102022BO2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.